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1. Introduction
  Wolbachia pipientis is an intracellular bacteria found in 
most of the arthropods, nematodes and isopods[1,2]. They are 
vertically transmitted rickettsia endosymbiont bacteria[3]. In 
order to ensure the parasite being successfully transmitted 
maternally, Wolbachia tend to alter reproduction properties 
of their host[4]. Common alteration that have been reported 
are male killing, feminization, parthenogenesis and 
cytoplasmic incompatibility (CI)[5,6]. Wolbachia modifies the 
spermatogenesis causing no viable offspring to be produced 
when infected male mates with uninfected female or female 
infected differently from the male[7]. Well understood CI can 
be used to reduce population of the host. 
  Aedes albopictus (Ae. albopictus) is an arthropod known 
to be naturally infected with Wolbachia pipientis bacteria. 
Most strains of Ae. albopictus screened in Malaysia were 
superinfected with both two Wolbachia strains (wAlbA 
and wAlbB). Aedes aegypti and Ae. albopictus are the 
major vectors for dengue in Malaysia. They are lethal 
vectors which transmit many deadly pathogens including 
dengue fever virus, chikungunya fever virus and West Nile 
Virus[8]. The combination of dengue blocking activity and 
rapid spread due to CI has led researchers to suggest that 
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Objective: To develop an artificial and modified Wolbachia removal technique using tetracycline 
from naturally Wolbachia infected Aedes albopictus (Ae. albopictus) so as to be able to produce 
generations of Wolbachia free offsprings.
Methods: In this study, seven different tetracycline treatment methods were conducted to obtain 
the best removal method. Four methods focused on larvae tetracycline treatment, one method on 
both larvae and adult tetracycline treatment and the last two methods on adult mosquito sucrose 
treatment. 
Results: All larval tetracycline treatments resulted in either high larvae mortality, sterile F0 adult 
mosquitoes or unsuccessful Wolbachia removal. Treatment of both larvae and adults resulted in 
reduced larvae mortality, successful Wolbachia removal but slow mosquito fecundity. As for the 
adult treatment, 1.0 mg/mL as previously published was not able to completely remove Wolbachia 
in F1 generation whereas 1.25 mg/mL successfully removed Wolbachia from F1 and F2 mosquitoes 
in 2 weeks. 
Conclusions: This method is different from the previously published methods as it provides an 
improved Wolbachia removal technique from Ae. albopictus with high egg hatchability, low larvae 
mortality, increased fecundity and better Wolbachia removal rate.
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Wolbachia can be used to develop public health strategies to 
reduce dengue incidence in human[9,10].
   In order to study the CI and effect of Wolbachia on 
Malaysian Ae. albopictus, it is necessary to have both 
Wolbachia infected and uninfected strains. 
  Ae. albopictus is a species naturally infected with 
Wolbachia therefore obtaining a natural strain without 
Wolbachia would be very rare[11]. Therefore an artificial 
Wolbachia removal technique is needed. 
  Previous studies have suggested treatment of larvae 
with tetracycline antibiotic to remove Wolbachia from Ae. 
albopictus[3,11]. However, reduced fecundity and egg viability 
was observed when the above mentioned method was 
implemented. Another study proposed treatment of only the 
adult mosquito with tetracycline antibiotic[11]. This managed 
to overcome the reduced fecundity and egg viability issue. 
However, when the method was implemented, the resulting 
offsprings were found not to be totally free from Wolbachia. 
  In this study, a modified Wolbachia removal method 
from Ae. albopictus is reported. It has minimal effect on 
the mosquito fecundity and egg viability and was able to 
produce generations of Wolbachia free offsprings.
2. Materials and methods
2.1. Mosquito strain
  A strain of Ae. albopictus obtained from Bukit Lagong, 
Selayang, Kuala Lumpur, Malaysia in August 2013 was used 
in this study. Mosquitoes were maintained in cages with 10% 
sucrose with 100 mg B-Complex solution. They were blood 
fed and eggs were collected weekly. Mosquito infection 
status was confirmed using polymerase chain reaction (PCR) 
amplification and sequencing.
2.2. Infection status
  A minimum of 30 blood fed mosquitoes were randomly 
caught for each new generation, blood fed, allowed to lay 
eggs and then extracted using Dneasy Blood and Tissue 
Extraction Kit according to the protocol provided by the 
manufacturer (Qiagen, CA, USA). Extracted DNA were stored 
at -20 °C until needed. All samples were screened for the 
presence of Wolbachia using multiplex PCR with Promega 
(Promega, Madison, WI) reagents for amplification of the 
wsp gene with diagnostic primers (Genomics BioSci & Tech, 
China). 
  The wAlbA strain gene was amplified with the wsp 328F 
and 691R primer pair whereas wAlbB strain gene was 
amplified with the wsp 183F and 691R primer pair. PCR was 
conducted in a 20 µL reaction per individual. This consisted 
of 10 µL ddH2O, 4 µL 5X Green GoTaq® Flexi Buffer, 1.6 µL 
magnesium chloride, 0.4 µL dNTPs, 0.6 µL of each primer 
(183F, 328F and 691R), 0.2 µL of GoTaq® Flexi DNA polymerase 
and 2 µL template. Samples were denatured for 5 min at 94 °C, 
followed by 35 cycles of 1 minute at 94 °C, 1 min at 55 °C and 
1 min at 72 °C. A negative control was run along with each 
batch of PCR amplification by substituting 2 µL of sample 
with 2 µL of ddH2O[12]. 
  A total of 8 µL of each sample was run in 1% agarose gel 
to detect the presence of amplified DNA fragments. One 
hundred kilobyte ladder (Promega, Madison, WI) was used 
to confirm presence of wAlbA (363 bp) and wAlbB (508 bp) 
genes[12] (Figure 1). 
Figure 1. Gel electrophoresis result image. Lane 1 is the 100 kB ladder. Lane 
2-6 are my samples. 
The upper row are wAlbB amplified gene at 508 bp and the lower row bands 
are wAlbA amplified gene at 363 bp. 
2.3. Tetracycline treatment
  All Wolbachia removal studies were conducted on strains 
with confirmed wAlbA and wAlbB superinfection. Studies 
were conducted as stated in Table 1. Treatment 1 was 
conducted as previously described by Otsuka and Takaoka 
in 1997[3]. Treatment 5 and 6 were conducted as described 
previously by Dobson and Rattanadechakul in 2001[11]. 
Treatments 2, 3, 4 and 7 consisted of a modified technique 
were conducted by this group. Larvae after the treatment 
period in treatment 1, 2, 3 and 4 were transferred back into 
water without tetracycline and reared to adulthood. In each 
treatment, randomly caught 25 blood fed adult mosquitoes 
were allowed to lay eggs first and then tested for presence 
of Wolbachia using PCR method as mentioned above. If no 
Wolbachia infection was found in all tested mosquitoes, 
the eggs obtained were hatched. Larvae after 24 h treatment 
in treatment 5 was transferred back into water without 
tetracycline and reared to adulthood.
Table 1 
Tetracycline treatment design.
Treatment Life cycle stage Treatment 
period (h)
Concentration of tetracycline
1
[a]
24th-48th hour larvae 24 5.00 mg/mL in 2 L overnight water
2
[c]
24th-72nd hour larvae 72 1.25 mg/mL in 2 L overnight water
3
[c]
48th-120th hour larvae 72 1.25 mg/mL in 2 L overnight water
4
[c]
48th-72th hour larvae 24 1.25 mg/mL in 2 L overnight water
5
[b]
48th-72th hour larvae 24 1.25 mg/mL in 2 L overnight water
Newly emerged adult mosquito Continuous 0.50 mg/mL in 10% sucrose solution with 100 mg B-Complex
6
[b]
Newly emerged adult mosquito Continuous 1.00 mg/mL in 10% sucrose solution with 100 mg B-Complex
7
[c]
Newly emerged adult mosquito Continuous 1.25 mg/mL in 10% sucrose solution with 100 mg B-Complex
[a]: Conducted as previously described by Otsuka and Takaoka in 1997[3]. 
[b]: Conducted as described previously by Dobson and Rattanadechakul in 2001[9].
[c]: Modified techniques conducted by this group.
   Adult mosquitoes in treatment 5, 6 and 7 were blood fed 
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after two weeks and one month for egg collection. Twenty 
five mosquitoes from which eggs were collected were tested 
for presence of Wolbachia using PCR method as mentioned 
above. Eggs collected from the treatment 5, 6 and 7 were 
allowed to hatch in 2 L overnight water. Egg hatching 
rate were calculated to determine egg viability for each 
treatment. Once the F1 generation mosquitoes were obtained, 
25 blood fed adult mosquitoes were randomly caught from 
each colony, allowed to lay egg first and then tested for 
presence of Wolbachia using PCR method as mentioned 
above. Average Wolbachia infectivity of F1 for treatment 
6 and 7 was obtained by calculating the mean infected 
mosquito numbers for three replicates of Wolbachia testing. 
The same calculation was done for average Wolbachia 
infectivity of F2 for treatment 7. 
3. Results
  The strain of Ae. albopictus used in this study had 100% 
both wAlbA and wAlbB infection. Figure 1 shows the result 
of PCR amplification when both wAlbA and wAlbB is present. 
The F4 eggs were used in this Wolbachia removal study. 
  Percentage of eggs hatched that survived to pupation, 
percentage of adult mosquitoes emerged, percentage of 
Wolbachia infection status of the F0 and percentage of F1 
eggs hatched were calculated for all treatments 1-7. Results 
are shown in Table 2. 
Table 2 
Percentage eggs hatch in F0 and F1 tetracycline treated strains.
Treatment
No. of 
eggs (F0)
Pupae after 5 d
Adult 
mosquito (F0)
Wolbachia infection status
No. of eggs 
obtained (F1)
Eggs hatch
1 132 4 (3.00%)   4 (100.00%) All 4 Wolbachia free (100.0%) 0 NA
2 111 6 (5.41%)  5 (83.30%) All 5 Wolbachia free (100.0%) 0 NA
3 122 42 (34.43%) 32 (76.19%) All 25 tested Wolbachia free (100.0%) 5 0 (0.00%)
4 142 88 (61.97%) 83 (94.32%) 13 out of 25 Wolbachia free (52.0%) 29 0 (0.00%)
5
[x]
145 82 (56.55%) 78 (95.12%) All 25 tested Wolbachia free (100.0%) 230 41 (17.83%)
6
[y]
153 107 (70.00%) 105 (98.13%) All 25 tested Wolbachia free (100.0%) 249 142 (57.03%)
7
[z]
143 92 (64.34%) 88 (95.65%) All 25 tested Wolbachia free (100.0%) 189 98 (51.85%)
[x]: Emerged mosquitoes were treated with 0.5 mg/mL tetracycline treated sucrose 
solution. F0 adult mosquitoes were only Wolbachia free after 1 month of treatment. 
[y]: Emerged mosquitoes were treated with 1.0 mg/mL tetracycline treated sucrose 
solution. F0 adult mosquitoes were only Wolbachia free after 1 month of treatment. 
[z]: Emerged mosquitoes were treated with 1.25 mg/mL tetracycline treated sucrose 
solution. F0 adult mosquitoes were Wolbachia free after 2 weeks of treatment. NA: 
Not applicable.
  Treatment 5, 6 and 7 had F1 eggs therefore studies were 
continued to obtain the percentage of F1 adult mosquitoes, 
Wolbachia infectivity status of F1 colony and Wolbachia 
infectivity status of F2 colony (only treatment 7). Results for 
this continuation studies are shown in Table 3. 
4. Discussion
  Tetracycline is a group of broad-spectrum antibiotics. Its 
overall usage has been reduced with the increasing bacterial 
resistance[13]. Since Wolbachia is an endosymbiotic bacteria, 
tetracycline at the right concentration and delivery method 
should be able to remove them from their respective hosts. 
This concurs with previous studies conducted[11]. 
   Treatment 1 which was conducted based on Otsuka method 
was not effective in this study as it caused low egg viability, 
high larval mortality and sterile adult mosquitoes[3]. Same 
issue have been reported by Dobson and Rattanadechakul in 
2001[11]. This may have been due to the high concentration of 
the tetracycline used to treat the larvae. 
   Similar larval treatments were carried out with reduced 
concentration to 1.25 mg/mL in treatment 2, 3 and 4 at 
different exposure periods. 
   High larval mortality was observed when larvae were 
treated for more than 24 h. However, improved larval 
mortality was observed when the 48 h larvae were treated 
instead of the 24 h larvae. This may be because 24 h larvae 
are too young to withstand the tetracycline treatment. 
  Treatment 4 was designed to expose 48 h larvae for 24 h 
which gave lower larval mortality and a higher percentage of 
adults.
  Although low larval mortality was observed, the treatment 
failed to remove Wolbachia completely from all surviving 
adults. Therefore it can be concluded that perhaps the 
period of treatment or tetracycline concentration was not 
sufficient.
  Treatment 5 was conducted based on Dobson report in 
2001 which subjects both larvae and adult mosquitoes 
tetracycline[11]. This method had low larval mortality and 
was able to completely remove Wolbachia from all surviving 
F0 adults. A good number of F1 eggs were obtained but 
the hatching rate of the F1 eggs was very low compared to 
untreated strains.
  Treatment 6 was conducted based on the final method 
from Dobson paper in 2001 which treats only the adult with 
1.0 mg/mL[11]. No alternative food source was provided 
for the mosquitoes. F0 Adult mosquitoes were tested for 
Wolbachia after 2 weeks exposure to tetracycline sucrose 
treatment. Mosquitoes were not found to be completely 
free of Wolbachia. F0 adult mosquitoes were again tested 
for Wolbachia after 1 month tetracycline treatment and all 
were Wolbachia free. Eggs were collected and F1 mosquitoes 
were obtained. Although the experiment was repeated three 
times, we failed to obtain entirely Wolbachia free F1 adult 
mosquitoes. Therefore treatment 6 as proposed by Dobson 
was not effective in this study. 
   Treatment 7 was designed exactly as treatment 6 with a 
Table 3
Wolbachia infectivity status of F1 and F2 tetracycline treated strains.
Treatment No. of larvae No. of adults (F1) Average Wolbachia infectivity of F1 Average Wolbachia infectivity of F2
5 41   32 (78.05%) All 25 tested Wolbachia free (100.0%) Not applicable because no eggs was obtained
6 142 130 (91.55%) 18 out of 25 Wolbachia free (72.0%) Not applicable
7 98   92 (93.88%) All 25 tested Wolbachia free (100.0%) All 25 tested Wolbachia free (100.0%)
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slight increment of the concentration of tetracycline in the 
sucrose solution. Complete Wolbachia removal from the F0 
adult mosquitoes was observed in two weeks tetracycline 
treated mosquitoes. This was confirmed with two replicates. 
Egg hatching rate was slightly lower than treatment 6 and 
93.88% became F1 adults. In contrast to treatment 6, F1 adults 
were 100% Wolbachia free. Average was obtained from three 
replicates. All F2 adults was also found to be Wolbachia free.
   Tetracycline treatment of only adult mosquitoes simplifies 
the process, improves the egg hatchability, reduces 
larval mortality and increases adult fecundity. The best 
concentration for the adult treatment is concluded to be 
1.25 mg/mL in sucrose solution with no alternative food 
source. This method is able to remove both wAlbA and 
wAlbB completely in just two weeks and gives subsequent 
generations free of Wolbachia.
  This self-sustaining Wolbachia free Ae. albopictus colony 
developed can be used to study the effect of Wolbachia on 
Malaysian Ae. albopictus. Future research may be conducted 
to develop a singly infected Ae. albopictus strain with a 
modified antibiotic treatment as none has been established 
so far.
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Comments 
Background
  There is increasing interest on Wolbachia endosymbionts 
in Aedes vectors as they are related to fecundity and to 
dengue transmission. There is a need to obtain strains of Ae. 
albopictus free from endosymbionts but existing methods 
through treatment of larvae with tetracycline have not been 
satisfactory.
 
Research frontiers
   An improved method to obtained Wolbachia free and 
viable Ae. albopictus mosquitoes for further studies.
Related reports
   Although the use of tetracycline to obtain Wolbachia free 
Aedes has been previously studied, the dosage and methods 
used did not produce satisfactory results.
Innovations and breakthroughs
   An improved method of using tetracycline in obtaining 
subsequent generations of Wolbachia free Ae. albopictus.
 
Applications
   This study is important for research on Wolbachia and 
dengue susceptibility.
Peer review
  The study has provided a viable method to produce 
Wolbachia free Ae. albopictus which is increasingly 
implicated as a vector of dengue transmission in many 
endemic countries. Susceptibility studies with dengue 
serotypes in Wolbachia positive or negative mosquitoes will 
be easily available now.
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